Search results
Merck Stock Jumps After Dow Jones Stalwart Rides Its Cancer 'Star' To Another Quarterly Beat
Investor's Business Daily· 2 days agoPAH is a form of high blood pressure in the lungs. Merck bought the drug's maker for $11.5 billion...
British man tests first personalised melanoma vaccine
BBC via Yahoo News· 2 days agoThese include tiredness and a sore arm when the jab was given, she said, adding that for the...
British patients test world’s first personalised mRNA jab for melanoma
Press Association News via AOL· 2 days ago“We’ve looked for a long time for something that would be additive to the immunotherapies that we...
FDA approves bladder cancer treatment by Culver City company
LA Times via Yahoo News· 5 days agoOverall, the median length of time that patients remained cancer-free after treatment was 19.3...
Treatment Options for HER2-Negative Breast Cancer
Healthline· 3 days agoMost breast cancers are HER2-negative. There are many treatment options for this type of breast cancer. Your treatment will depend on factors such as...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 6 days agoNew York, USA, April 22, 2024 (GLOBE NEWSWIRE) -- EGFR Inhibitor Market to Accelerate Substantially During the Study Period (2020–2034) | DelveInsight According to DelveInsight’s analysis, the growth of the EGFR inhibitor market is expected